Functional dyspepsia and non-erosive reflux disease: A review

Minerva Gastroenterologica e Dietologica

Volumn 52, Issue 3, 2006, Pages 261-267

  Keohane, J ^a   Quigley, E M M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Dyspepsia; Functional disorders; Functional dyspepsia; Gastroesophageal reflux disease; Non erosive reflux disease

Indexed keywords

GASTROINTESTINAL AGENT; PROTON PUMP INHIBITOR;

CLINICAL TRIAL; DRUG EFFICACY; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GENERAL PRACTITIONER; HEALTH CARE COST; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERSENSITIVITY; NONEROSIVE REFLUX DISEASE; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; STOMACH ACID SECRETION; STOMACH DISTENSION; STOMACH EMPTYING; STOMACH PH; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

DYSPEPSIA; GASTROESOPHAGEAL REFLUX; HUMANS;

EID: 33750627642     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Quigley EM. Functional dyspepsia (FD) and non-erosive reflux disease (NERD): overlapping or discrete entities? Best Pract Res Clin Gastroenterol 2004;18:695-706.
2. Post PN, Kuipers EJ, Meijer GA. Declining incidence of peptic ulcer but not of its complications: a nation-wide study in The Netherlands. Aliment Pharmacol Ther 2006;23;1587-93.
3. Moayyedi P, Forman D, Braunholtz D, Feltbower R, Crocombe W, Liptrott M et al. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and non-steroidal anti-inflammatory drugs. Leeds HELP Study Group. Am J Gastroenterol 2000;95:1448-55.
4. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999;45 Suppl 2:037-1142.
5. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-79.
6. Moayyedi P, Talley NJ, Fennerty MB, Vakil N. Can the clinical history distinguish between organic and functional dyspepsia? JAMA 2006;295:1566-76.
7. Fass R, Fennerty MB, Vakil N. Nonerosive reflux disease - current concepts and dilemmas. Am J Gastro-enterol 2001;96:303-14.
8. Tew S, Jamieson GG, Pilowsky I, Myers J. The illness behavior of patients with gastroesophageal reflux disease with and without endoscopic esophagitis. Dis Esophagus 1997;10:9-15.
9. Quigley EM. Non-erosive reflux disease: part of the spectrum of gastro-oesophageal reflux disease, a component of functional dyspepsia, or both? Eur J Gastroenterol Hepatol 2001;13 Suppl 1:S13-S18.
10. Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist H et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997;32:974-9.
11. Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992;51 Suppl 1:24-9.
12. Eggleston A, Wigerinck A, Huijghebaert S, Dubois D, Haycox A. Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice: a clinical database analysis. Gut 1998;42:13-6.
13. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004;19:643-54.
14. Locke GR, III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ, III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-56.
15. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003 Oct 15;18(8):767-76.
16. Quigley EM, DiBaise JK. Non-erosive reflux disease: the real problem in gastro-oesophageal reflux disease. Dig Liver Dis 2001;33:523-7.
17. Bolling-Sternevald E, Carlsson R, Aalykke C, Wilson BV, Junghard O, Glise H et al. Self-administered symptom questionnaires in patients with dyspepsia and their yield in discriminating between endoscopic diagnoses. Dig Dis 2002;20:191-8.
18. Keohane J, Quigley EM. Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis. World J Gastroenterol 2006;12:2672-6.
19. Talley NJ, Stanghellini V, Heading RC. Functional gastroduodenal disorders. In: Drossman DA., Corrazziari E, Talley NJ, Thompson WG, Whitehead WE, editors. Rome II. The functional gastrointestinal disorders: diagnosis, pathophysiology, and treatment: a multinational consensus. 2nd ed. McClean, Virginia: Degon Associates; 2000.p.299-350.
20. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004;127:1239-55.
21. Stanghellini V, Tosetti C, Paterni A, Barbara G, Morselli-Labate AM, Monetti N et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996;110:1036-42.
22. Gilja OH, Hausken T, Wilhelmsen I, Berstad A. Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci 1996;41:689-96.
23. Kim DY, Gado-Aros S, Camilleri M, Samsom M, Murray JA, O'Connor MK et al. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol 2001;96:3099-105.
24. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998;115:1346-52.
25. Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J. Transient lower esophageal sphincter relaxation. Gastroenterology 1995;109:601-10.
26. George AA, Tsuchiyose M, Dooley CP. Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia. Gastroenterology 1991;101:3-6.
27. Lee KJ, Vos R, Janssens J, Tack J. Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am J Physiol Gastrointest Liver Physiol 2004;286:G278-G284.
28. Samsom M, Verhagen MA, vanBerge Henegouwen GP, Smout AJ. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999;116:515-20.
29. Bolling-Sternevald E, Lauritsen K, Talley NJ, Junghard O, Glise H. Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? Aliment Pharmacol Ther 2003;18:117-24.
30. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998;12:1055-65.
31. Dent J. Gastro-oesophageal reflux disease. Digestion 1998;59:433-45.
32. Hopwood D, Milne G, Logan KR. Electron microscopic changes in human oesophageal epithelium in oesophagitis. J Pathol 1979;129:161-7.
33. Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux: damaged human esophageal epithelium. Gastroenterology 1996;111:1200-5.
34. Fass R, Ofman JJ. Gastroesophageal reflux disease: should we adopt a new conceptual framework? Am J Gastroenterol 2002;97:1901-9.
35. Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD): acid reflux and symptom patterns. Aliment Pharmacol Ther 2003;17:537-45.
36. Cicala M, Emerenziani S, Caviglia R, Guarino MP, Vavassori P, Ribolsi M et al. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003;18:605-13.
37. Watson RG, Tham TC, Johnston BT, McDougall NI. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux: the "sensitive oesophagus". Gut 1997;40:587-90.
38. Clouse RE, Richter JE, Heading RC, Janssens J, Wilson JA. Functional esophageal disorders. Gut 1999;45 Suppl 2:II31-II36.
39. Galmiche JP, Clouse RE, Balint A, Cook IJ, Kahrilas PJ, Paterson WG et al. Functional esophageal disorders. Gastroenterology 2006;130:1459-65.
40. Vu MK, Straathof JW, Schaar PJ, Arndt JW, Ringers J, Lamers CB et al. Motor and sensory function of the proximal stomach in reflux disease and after laparoscopic Nissen fundoplication. Am J Gastroenterol 1999;94:1481-9.
41. Penagini R, Hebbard G, Horowitz M, Dent J, Bermingham H, Jones K et al. Motor function of the proximal stomach and visceral perception in gastro-oesophageal reflux disease. Gut 1998;42:251-7.
42. DiBaise JK, Lof J, Akromis I, Quigley EMM. An open-label comparison of omeprazole and cisapride in endoscopy-negative reflux disease. Am J Gastroenterol 1999;94:A2583.
43. Fass R. Empirical trials in treatment of gastroesophageal reflux disease. Dig Dis 2000;18:20-6.
44. Bate CM, Griffin SM, Keeling PW, Axon AT, Dronfield MW, Chapman RW et al. Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther 1996;10:547-55.
45. Parley A, Wruble LD, Humphries TJ. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group. Am J Gastroenterol 2000;95:1894-9.
46. van PB, Numans ME, Bonis PA, Lau J. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2004;(4): CD002095.
47. Bolling-Sternevald E, Lauritsen K, Aalykke C, Havelund T, Knudsen T, Unge P et al. Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 2002;37:1395-402.
48. Hatlebakk JG, Johnsson F, Vilien M, Carling L, Wetterhus S, Thogersen T. The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease. Scand J Gastroenterol 1997;32:1100-6.
49. Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Tan S et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999;3:292-300.
50. Eubanks TR, Omelanczuk P, Richards C, Pohl D, Pellegrini CA. Outcomes of laparoscopic antireflux procedures. Am J Surg 2000;179:391-5.
51. Vu MK, Ringers J, Arndt JW, Lamers CB, Masclee AA. Prospective study of the effect of laparoscopic hemifundoplication on motor and sensory function of the proximal stomach. Br J Surg 2000;87:338-43.
52. Bais JE, Samsom M, Boudesteijn EA, van Rijk PP, Akkermans LM, Gooszen HG. Impact of delayed gastric emptying on the outcome of antireflux surgery. Ann Surg 2001;234:139-46.